People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Manufacturing, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Butterfly Health, Inc. | — | Manufacturing | Series A | $13.6M | $30.5M | 2012 |
| Phenomix Sciences, Inc. | — | Other Health Care | Series A | $8.6M | $7.1M | 2024 |
Karl Ronn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Karl Ronn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wende Hutton | 1 | 16 |
| Mark Bagnall | 1 | 3 |
| LAWRENCE COHEN | 1 | 3 |
| Lawrence K Cohen | 1 | 2 |
| Andres Acosta | 1 | 2 |
| Michael Camilleri | 1 | 2 |
| Karl K Ronn | 1 | 1 |
| Mark Bengall | 1 | 1 |
| Kelly Lewis Brezoczky | 1 | 1 |
| Wende P Hutton | 1 | 1 |
| David P Alberga | 1 | 1 |
| Paul P Crawley | 1 | 1 |
| Karl P Ronn | 1 | 1 |
| Bryan P Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.